Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP

35.48

+0.31 (+0.88%)

4:59:20 PM EDT: $35.74 +0.26 (+0.73%)

Market Cap (Intraday)	263.33M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$2.6 Million
Adjusted EPS	-$5.18

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Tonix Pharmaceuticals Holding Corp Stock, NASDAQ:TNXP

26 Main Street, Suite 101, Chatham, New Jersey 07928

United States of America

Phone: +1.862.799.8599

Number of Employees: 103

http://www.tonixpharma.com

Description

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.